10-K Decoder · All companies

Viridian Therapeutics, Inc.

VRDN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$70.8M$300K+23,517%
Operating income−$363M−$299M−21.5%
Net income−$343M−$270M−26.9%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$25.8M$70.6M−63.5%
Operating income−$104M−$40.0M−159%
Net income−$101M−$34.6M−192%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Viridian's revenue in FY2025?
$70.8M in FY2025 (Fiscal year ended Dec 31, 2025), +23,517% vs $300K a year earlier, per its 10-K filed Feb 2026.
Was Viridian profitable in FY2025?
No: net income was −$343M and operating income −$363M in FY2025.
What was Viridian's revenue in Q3 2026?
$25.8M (−63.5% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.